Table 1 Clinicopathological correlation of FASN expression in Human liver cancer.
Clinicopathological features | Â | FASN low | FASN high | P value |
---|---|---|---|---|
Gender | Male | 28 | 24 | >0.9999 |
 | Female | 10 | 8 |  |
Tumor size, cm | <5 | 22 | 10 | 0.0321* |
 | ≥5 | 16 | 22 |  |
Number of tumor nodules | 1 | 30 | 23 | 0.5804 |
 | ≥2 | 8 | 9 |  |
Venous invasion | Present | 13 | 21 | 0.0158* |
 | Absent | 25 | 11 |  |
Tumor microsatellite formation | Present | 17 | 18 | 0.472 |
 | Absent | 21 | 14 |  |
Direct liver invasion | Present | 15 | 22 | 0.0145* |
 | Absent | 23 | 10 |  |
Tumor encapsulation | Present | 20 | 14 | 0.4823 |
 | Absent | 18 | 18 |  |
Cellular differentiation according to Edmondson’s grading | Grades l | 16 | 13 | 0.9388 |
 | Grades Il–IV | 23 | 18 |  |
Background liver diseases | Normal and chronic hepatitis | 17 | 12 | 0.7134 |
 | Cirrhosis | 13 | 14 |  |
 | Steatohepatitis | 8 | 6 |  |
T stage | T1 | 11 | 7 | 0.5 |
 | T2-4 | 27 | 25 |  |
N stage | N0 | 37 | 31 | >0.999 |
 | N1 | 1 | 1 |  |
M stage | M0 | 38 | 32 | >0.999 |
 | M1 | 0 | 0 |  |
MVI | M0 | 23 | 19 | >0.999 |
 | M1,M2 | 15 | 13 |  |